Ley receives $6.4 million NCI award for leukemia research​​

​​Timothy J. Ley, MD, a leukemia researcher and hematologist at the School of Medicine, has received a seven-year, $6.4 million Outstanding Investigator Award from the National Cancer Institute (NCI) of the National Institutes of Health (NIH). The funding will allow him to continue research aimed at understanding the mutations that initiate acute myeloid leukemia (AML), and how they might be targeted with new approaches.
Siteman Cancer Center earns highest rating from federal cancer institute​​​​​​​​​

Siteman Cancer Center earns highest rating from federal cancer institute​​​​​​​​​

The National Cancer Institute (NCI) has awarded Siteman Cancer Center​ at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis an “exceptional” rating, based on a rigorous review of Siteman’s research programs. The rating is the highest possible by the NCI, the principal federal institute that funds cancer research.

Students win Breast Cancer Startup Challenge

An interdisciplinary group of graduate students including Washington University’s (from left) Anurag Agarwal, Whitney Grither and Hirak Biswas was one of 10 winning teams in the Breast Cancer Startup Challenge. The international competition aimed to bring breast cancer discoveries out of the lab and closer to market to help patients.

University receives $26 million for leukemia research

The National Cancer Institute has awarded two major grants totaling $26 million to leukemia researchers and physicians at the School of Medicine. The funding has the potential to lead to novel therapies for leukemia that improve survival and reduce treatment-related side effects. Pictured are cancer cells from a patient with acute myeloid leukemia.

Chest X-rays don’t reduce lung cancer deaths

A major U.S. study shows that annual chest X-rays to screen for lung cancer do not reduce the risk of dying from the disease, even in smokers or former smokers. More than 150,000 older Americans were involved in the clinical trial, funded by the National Cancer Institute, with about 16,000 enrolled at Washington University School of Medicine in St. Louis. Results of the study will be published Nov. 2 in the Journal of the American Medical Association.

CT screening reduces lung-cancer deaths in heavy smokers

In a study of heavy smokers, fewer screened with low-dose CT scans died, compared with similar smokers screened with standard chest X-rays. The National Cancer Institute ran the 33-center National Lung Screening Trial to learn whether more sensitive screening could have an impact on lung-cancer deaths, and Washington University researchers involved in the study say it did.